TBS iNsight (Osteo)

Medimaps Group

Medimaps developed TBS iNsight™ (Osteo) to assess the microarchitectural deterioration of bone tissue – a characteristic of osteoporosis. It computes a Trabecular Bone Score™ (TBS), which provides clinical information as to the microarchitecture of the bone.
Product specifications Information source: Public
Last updated: Jan. 27, 2020
General
Product name TBS iNsight (Osteo)
Company Medimaps Group
Subspeciality MSK
Modality X-ray
Disease targeted osteoporosis
Key-features Trabecular Bone Score calculation, fracture risk assessment
Suggested use
Data characteristics
Population
Input DXA 2-D images produced during a regular spine Bone Mineral Density (BMD) scan
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time
Certification
CE Certified, Class unknown
FDA 510(k) cleared, Class II
Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers